Hualan Biological Engineering Inc(002007) : the IPO of Hualan vaccine gem, a holding subsidiary, was registered by the CSRC
Hualan Biological Engineering Inc(002007) (002007) announced on January 12 that according to the reply on Approving the registration of initial public offering shares of Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. issued by the CSRC on January 12, the CSRC agreed to the registration application of Hualan vaccine, a holding subsidiary, for initial public offering shares on the gem.
Zhenhai Petrochemical Engineering Co.Ltd(603637) : Zhao Liwei and other 40 natural persons plan to transfer 5.04% of the company’s shares to Shuntong group
Zhenhai Petrochemical Engineering Co.Ltd(603637) (603637) announced on January 12 that 40 natural persons such as Zhao Liwei, fan Qihai, fan Xiaomei and Weng Wei planned to transfer 5.04% of the company’s shares held by them to Shuntong group at a transfer price of 14.28 yuan per share, with a total transfer price of 175 million yuan. Meanwhile, Shuntong group, Shunjian group, Zhao Liwei, fan Qihai, fan Xiaomei and Weng Wei signed the agreement on concerted action. After the completion of this share transfer, Shuntong group will hold 16.53% of the shares of the company and become the largest shareholder of the company.
Andon Health Co.Ltd(002432) : it is uncertain whether the family self-test box recommended to Tianjin will be adopted for epidemic prevention
Andon Health Co.Ltd(002432) (002432) on January 12, the company issued the announcement of abnormal stock trading fluctuation and risk warning. Previously, the company submitted the proposal on using family self-test box to realize Omicron covid-19 epidemic prevention 1 + 1 to Tianjin epidemic prevention and control headquarters. At present, relevant departments are studying the proposal, and it is uncertain whether the proposal will be adopted.
Cssc Science & Technology Co.Ltd(600072) : it is proposed to issue shares to purchase assets and raise supporting funds, and the trading will be resumed from the 13th
Cssc Science & Technology Co.Ltd(600072) (600072) announced on January 12 that the company plans to issue RMB ordinary shares to the counterparty to purchase 100% shares of China haizhuang, 10% shares of lingjiu electric, 44.64% shares of Luoyang Shuangrui, 88.58% shares of CSCEC wind power and 100% shares of Xinjiang Haiwei held by the counterparty. At the same time, it plans to issue shares to no more than 35 qualified specific investors to raise supporting funds, The trading of the company’s shares will resume from the opening of the market on January 13.
Sichuan Haowu Electromechanical Co.Ltd(000757) : some 4S stores under the subsidiary suspended their operations due to the epidemic
Sichuan Haowu Electromechanical Co.Ltd(000757) (000757) announced on January 12 that 19 companies under Jiang Pengxiang, a wholly-owned subsidiary of the company, are located in Tianjin, of which 5 4S stores have been suspended in accordance with the requirements of covid-19 epidemic prevention and control in Tianjin; In order to fully cooperate with the epidemic prevention work, the remaining 14 4S stores and 3 other subordinate companies have orderly controlled the flow of employees or work at home according to the epidemic prevention and control requirements. The specific time for resumption of operation will be determined according to the overall progress of epidemic prevention and control in Tianjin. It is expected to have a certain adverse impact on the company’s operating performance in 2022.
Asahi biology: it is proposed to use the over raised funds to invest in the R & D and production project of in vitro diagnostic reagents and diagnostic instruments
E company news, an Xu Biology (688075) announced on January 11 that with the outbreak of covid-19 epidemic, the demand for real-time detection reagents and detection instruments in various countries around the world has greatly increased, especially in the foreign market. The company plans to invest in the development and production of in vitro diagnostic reagents and diagnostic instruments, which will be implemented by the wholly-owned subsidiary xumin biology, with an estimated total investment of 508 million yuan. The total amount of over raised funds of the company is 597 million yuan, and it is planned to use part of the over raised funds to invest in the project. After the completion of the project, the production scale of the company will be further expanded and the automation level of the production line will be improved.
Citic Securities Company Limited(600030) performance express: net profit in 2021 increased by 54.2% year-on-year
Citic Securities Company Limited(600030) (600030) disclosed the performance express on January 12, and achieved an operating revenue of 76.570 billion yuan in 2021, a year-on-year increase of 40.80%; The net profit was 22.979 billion yuan, a year-on-year increase of 54.2%.
Sichuan Yahua Industrial Group Co.Ltd(002497) : the net profit in 2021 is expected to increase by 184.09% – 224.23%
Sichuan Yahua Industrial Group Co.Ltd(002497) (002497) announced on January 12 that the company’s pre profit in 2021 was 920 million yuan – 1.05 billion yuan, a year-on-year increase of 184.09% – 224.23%. During the reporting period, the company’s two main businesses of civil explosion and lithium industry continued to develop, the civil explosion business developed steadily, and the demand of lithium industry continued to rise; The company seized the new energy industry cycle, released production capacity and increased sales. The sales volume of lithium salt products increased significantly, the profit of lithium business increased significantly, and the overall profitability of the company increased significantly.
Petrochina Company Limited(601857) : the net profit in 2021 is expected to increase by 374% – 395%
Petrochina Company Limited(601857) (601857) disclosed the performance forecast on January 12. It is estimated that the net profit in 2021 will increase by 71 billion yuan to 75 billion yuan, a year-on-year increase of 374% to 395%. The sales of the company’s main oil and gas products increased both in quantity and efficiency.
